JPMorgan Chase & Co’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.7K | Buy |
1,921
+1,821
| +1,821% | +$65.2K | ﹤0.01% | 4956 |
|
|
2025
Q1 | $3.64K | Sell |
100
-1,937
| -95% | -$70.5K | ﹤0.01% | 5597 |
|
|
2024
Q4 | $44.8K | Buy |
+2,037
| New | +$44.8K | ﹤0.01% | 5044 |
|
|
2023
Q4 | – | Sell |
-1
| Closed | -$2 | – | 6634 |
|
|
2023
Q3 | $2 | Buy |
+1
| New | +$2 | ﹤0.01% | 6449 |
|
|
2023
Q2 | – | Sell |
-483
| Closed | -$3K | – | 6174 |
|
|
2023
Q1 | $3K | Buy |
+483
| New | +$3K | ﹤0.01% | 5482 |
|